Clinical Trials Sponsored by Fondazione Italiana Linfomi ONLUS

Total 99 results

Fondazione Italiana Linfomi - ETS

Active, not recruiting

A Phase III Multicenter, Randomized Study Comparing RIT Vs ASCT in Patients With Relapsed/Refractory (FL)

Relapsed Follicular Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Terminated

Use of Venetoclax as Single Agent in Patients With Relapsed/Refractory BCL-2 Positive Peripheral T Cell Lymphoma

T-Cell Lymphoma Relapsed | T-Cell Lymphoma Refractory

Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas (FIL_PTCL13)

Peripheral T-cell Lymphomas (PTCL) | PTCL-NOS | Angioimmunoblastic T-cell Lymphoma (AITL) | ALK- Anaplastic Large Cell Lymphoma (ALCL) | Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin

Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients (FIL_RENOIR12)

Lymphoma, Follicular

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto
Fondazione Italiana Linfomi

Recruiting

Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.

COVID-19 | Chronic Lymphocytic Leukemia | Indolent B-Cell Non-Hodgkin Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Not yet recruiting

Lifestyles Implemented-Survivorship Care Plan In Lymphoma Survivors

Classical Hodgkin Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Diffuse Large B Cell Lymphoma (DLBCL)

Italy
Fondazione Italiana Linfomi - ETS

Recruiting

Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients. (FIL_COLUMN)

Refractory Mantle Cell Lymphoma | Relapsed Mantle Cell Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Recruiting

Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.

Mantle Cell Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

The Role of 18F-FDG-PET for Staging and Prognostication

Mantle Cell Lymphoma

Portugal, Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

FIL Study on ABVD DD-DI as Upfront Therapy in HL.

Hodgkin Lymphoma

Italy
Fondazione Italiana Linfomi - ETS

Active, not recruiting

Indolent Non Follicular Lymphomas Prognostic Project

Indolent B-Cell Lymphomas

France, Italy, Brazil, Austria, Portugal, Ukraine
Fondazione Italiana Linfomi - ETS

Terminated

Idelalisib+Obinutuzumab in Patients With Relapsed/Refractory Follicular Lymphoma (GAUDEALIS)

Follicular Lymphoma

Italy
Fondazione Italiana Linfomi - ETS
AbbVie

Active, not recruiting

Rituximab, Bendamustine and Cytarabine Followed by Venetoclax in High Risk Elderly Patients With MCL

Lymphoma, Mantle-Cell

Italy
Fondazione ANT Italia ONLUS

Completed

Study on Quality of Life in Advanced Cancer Patients With Opioid-induced Constipation Treated With Naloxegol

Cancer | Opioid Use | Constipation Drug Induced

Italy
Fondazione Italiana Linfomi - ETS
Roche Pharma AG

Recruiting

Study of Atezolizumab Plus BEGEV Regimen in Relapsed or Refractory Hodgkin's Lymphoma Patients (FIL_A-BEGEV)

Relapsed or Refractory Hodgkin's Lymphoma

Italy
Fondazione Italiana Linfomi - ETS
Janssen-Cilag S.p.A.

Recruiting

Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance

DLBCL

Italy
Fondazione Italiana Linfomi - ETS
Roche Pharma AG

Not yet recruiting

R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma (FIL_POLARDHAP)

Diffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma Refractory

Italy
Fondazione Italiana Linfomi - ETS
Roche Pharma AG

Not yet recruiting

A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice (FIL_MAB)

Non-Hodgkin Lymphoma, B-cell

Italy
Fondazione Italiana Linfomi - ETS
Roche Pharma AG

Recruiting

Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi (FIL_GAZEBO)

Follicular Lymphoma

Italy
Fondazione Italiana Linfomi - ETS
Janssen-Cilag S.p.A.

Recruiting

Study to Evaluate Combined Treatment of Daratumumab, Bortezomib and Dexamethasone in PBL Patients. (FIL_DALYA)

Plasmablastic Lymphoma

Italy
Ospedale Santa Croce-Carle Cuneo
Fondazione Italiana Linfomi ONLUS; Consorzio Mario Negri Sud

Unknown

Dual Point PET Scan in Early Stage Hodgkin Lymphoma Patients With Bulky Lesions (2P-HD-10)

Hodgkin's Lymphoma

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients (HD0801)

Hodgkin's Lymphoma

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Unknown

Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma (REAL07)

Follicular Lymphoma | Non Hodgkin Lymphoma

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Unknown

Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma (DLCL04)

Diffuse Large B-Cell Lymphoma | IPI≥2

Italy
Fondazione Italiana Linfomi - ETS
Kite, A Gilead Company

Not yet recruiting

SARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR Project

Non-hodgkin Lymphoma,B Cell

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

Salvage Treatment With Lenalidomide and Dexamethaosne (LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL)

MANTLE CELL LYMPHOMA

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

A Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL) (HD0803)

Hodgkin Lymphoma

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular Lymphoma (FLE09)

Follicular Lymphoma

Italy
Fondazione Don Carlo Gnocchi Onlus
Fondazione Italiana Sclerosi Multipla

Recruiting

A Feasibility Pilot Study on Lee Silverman Voice Treatment-Loud: a Telerehabilitation Approach

Multiple Sclerosis

Italy
European Organisation for Research and Treatment...
Fondazione Italiana Linfomi ONLUS; Lymphoma Study Association

Unknown

Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma (H10)

Lymphoma

Netherlands
Fondazione Don Carlo Gnocchi Onlus
Istituto Auxologico Italiano

Recruiting

Salivary Biomarker Discovery by Raman Spectroscopy in ALS (SalivALS) (SalivALS)

Amyotrophic Lateral Sclerosis

Italy
Fondazione ANT Italia ONLUS
University of Bologna

Recruiting

Look of Life 2.0. Virtual Reality for Cancer Patients in Home Palliative Care (LOL2020_ANT)

Virtual Reality | Oncological Patients

Italy
Gruppo Italiano Multiregionale per lo studio dei...
University of Turin, Italy; Fondazione Italiana Linfomi ONLUS; Centro di Riferimento...

Completed

Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma (LYM-2023)

Lymphoma | Non-Hodgkin Lymphoma

Italy
Campus Bio-Medico University
Associazione Italiana di Ematologia e Oncologia Pediatrica; Fondazione Italiana...

Not yet recruiting

Multicentric and Retrospective Analysis of Adolescent Young Adult (AYA) Hodgkins' Lymphoma Patients

Hodgkin Lymphoma | Chemotherapy Effect | Adolescent Behavior
Fondazione Don Carlo Gnocchi Onlus
Istituto Italiano di Tecnologia

Recruiting

ACTive Exoskeleton for Unilaterally-Assisted Locomotion (ACTUAL) (ACTUAL)

Stroke Sequelae | Gait, Hemiplegic

Italy
Fondazione Don Carlo Gnocchi Onlus
Fondazione Italiana Sclerosi Multipla; Ente Ospedaliero Ospedali Galliera

Recruiting

Effect of High Intensity Training on Motor and Cognitive Functions (FAST)

Multiple Sclerosis

Italy
Fondazione Italiana Linfomi ONLUS
Janssen Pharmaceutica; Janssen-Cilag Ltd.; Centro di Riferimento per l'Epidemiologia...

Completed

Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP. (FIL_VERAL12)

Diffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-cell Lymphoma Refractory

Italy
Istituto Auxologico Italiano
Fondazione Serena Onlus - Centro Clinico NeMO Milano

Completed

Poor Neck Proprioception May Cause Balance Deficits in Myotonic Dystrophy 1 (CABLAMYD)

Myotonic Dystrophy 1

Italy
Associazione Angela Serra per la ricerca sul cancro
Fondazione Italiana Linfomi ONLUS; INTERNATIONAL T-CELL NON-HODGKIN'S LYMPHOMA...

Completed

T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma

Lymphoma, T-Cell, Peripheral

United States, Korea, Republic of, Spain, Italy, United Kingdom, China, Switzerland, Israel, France, Argentina, Brazil, Chile, Slovakia, Uruguay
Associazione Angela Serra per la ricerca sul cancro
Fondazione Italiana Linfomi ONLUS; The International Non-Hodgkin Lymphoma Prognostic...

Completed

Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)

Lymphoma, Follicular

United States, Spain, Italy, Switzerland, United Kingdom, Argentina, Czechia, France
Fondazione Don Carlo Gnocchi Onlus
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; FIMARP ONLUS -...

Enrolling by invitation

Illness Expectations in Pulmonary Fibrosis (CAMFP)

Pulmonary Fibrosis

Italy
Fondazione ANT Italia ONLUS
Vital Signals Touch srl (IppocraTech); Nethical srl

Recruiting

Telematics Device for Daily Monitoring of Vital Signs in Cancer (ButterfLife)

Cardiovascular Diseases | Cancer | Respiratory Disease

Italy
University of Cagliari
Fondazione Don Carlo Gnocchi Onlus; Italian Multiple Sclerosis Foundation; Azienda...

Unknown

Virtual Reality for Upper Limb Rehabilitation in Multiple Sclerosis

Multiple Sclerosis

Italy
San Camillo Hospital, Rome
Fondazione Italiana Sclerosi Multipla; Fondazione Don Carlo Gnocchi Onlus; University... and other collaborators

Recruiting

Home-based EXergames To impRove cognitivE Function in MUltiple Sclerosis (EXTREMUS)

Multiple Sclerosis

Italy
Fondazione Don Carlo Gnocchi Onlus
Associazione Italiana Glicogenosi (AIG); Associazione Riabilitatori Insufficienza... and other collaborators

Recruiting

Inspiratory Muscle Training (IMT) in Adult People With Pompe Disease (LOPD01)

Glycogen Storage Disease Type II | Pompe Disease (Late-onset)

Italy
Fondazione Policlinico Universitario Agostino Gemelli...
IRCCS Azienda Ospedaliero-Universitaria di Bologna; Fondazione I.R.C.C.S. Istituto... and other collaborators

Not yet recruiting

National Database of the Virtual Institute of Cerebrovascular Diseases (BIG-MENTI)

Cerebrovascular Disease

Italy
IRCCS National Neurological Institute "C. Mondino...
IRCCS Associazione Oasi Maria SS. ONLUS, Troina, Italy; IRCCS Istituto Auxologico... and other collaborators

Completed

Validation of the I-UDS Neuropsychological Battery

Alzheimer Disease | Mild Cognitive Impairment

Italy
Hasselt University
Charles University, Czech Republic; Queen's University; Haukeland University... and other collaborators

Completed

Psychometric Properties Upper Limb Function Measures Multiple Sclerosis (MCS-III-UL)

Multiple Sclerosis

Belgium
Hasselt University
Charles University, Czech Republic; Queen's University; Haukeland University... and other collaborators

Completed

Psychometric Properties Mobility Measures MS (MCS-III-MOB)

Multiple Sclerosis

Belgium

Clinical Trials Sponsored by Fondazione Italiana Linfomi ONLUS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations